Ocular Toxicity Associated With Antibody–Drug Conjugates: A Summary Resource

Download this summary resource for a quick guide on identifying and managing ocular toxicities associated with FDA-approved antibody-drug conjugates for patients with cancer.
Asim V. Farooq, MD
Joann Kang, MD
Format: Adobe Acrobat (.pdf)
File Size: 796 KB
Released: January 31, 2022


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from

Information on this Educational Activity


Asim V. Farooq, MD

Associate Professor of Ophthalmology
Vice Chair of Academic Affairs
Director of Medical Student Education
Department of Ophthalmology and Visual Science
University of Chicago Medical Center
Chicago, Illinois

Asim V. Farooq, MD, has disclosed that he has received consulting fees from Five Prime Therapeutics/Amgen and GlaxoSmithKline.
Joann Kang, MD

Associate Professor of Ophthalmology
Montefiore Medical Center/Albert Einstein College of Medicine
Director, Cornea and Refractive Surgery
Montefiore Medical Center
Bronx, New York

Joann Kang, MD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

Commentary on management challenges and incorporating novel therapies for gynecologic cancers, from Clinical Care Options (CCO)

Jubilee Brown, MD person default Elisabeth Diver, MD Released: July 5, 2022

Downloadable slideset with highlights from key hematologic cancers as presented at EHA 2022 Congress, from Clinical Care Options (CCO)

Stéphane de Botton, MD Jesús F. San-Miguel, MD, PhD Alessandra Tedeschi, MD Released: June 30, 2022

Experts discuss important new data from ASCO 2022 that may impact treatment for chronic lymphocytic leukemia and mantle cell lymphoma, from Clinical Care Options (CCO)

Brad S. Kahl, MD Anthony Mato, MD, MSCE Released: June 30, 2022

Downloadable clinical resource with practical guidance on how to talk with your transgender patients about gender identity, including related terminology, from Clinical Care Options (CCO)

Nelson F. Sanchez, MD
Program Director
Released: June 30, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings